Selective Estrogen Receptor Degraders

Novel selective estrogen receptor degraders (SERDs) according to the formula:, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R' or R2 is independently selected from Cl, F, -CF 3, or - CH3, and the other is hydrogen, and methods for their use...

Full description

Saved in:
Bibliographic Details
Main Authors COHEN, Jeffrey Daniel, BASTIAN, Jolie Anne, SALL, Daniel Jon, RUBIO, Almudena, MCMAHON, Jennifer Ann
Format Patent
LanguageEnglish
Published 30.06.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Novel selective estrogen receptor degraders (SERDs) according to the formula:, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R' or R2 is independently selected from Cl, F, -CF 3, or - CH3, and the other is hydrogen, and methods for their use are provided.
Bibliography:Application Number: AU20220203969